Journal of Carcinogenesis & Mutagenesis

Current Issue

Genotoxic Stress and DNA Repair Pathways in Mutagenesis, 2025

Commentary

The Power of Genetic Diversity in Nature and Evolution

• Chao Shen*

DOI: 10.35248/2157-2518.25.16.001

Commentary

The Role of DNA Alteration in Genetic Diversity and Biotechnology

• Xiaodong Xu*

DOI: 10.35248/2157-2518.25.16.002

Perspective

Epidemiological Trends and Therapeutic Advances in the Management of Adenocarcinoma

• Claudio Scafoglio*

DOI: 10.35248/2157-2518.25.16.003

Opinion

The Clinical and Pathological Features of Lymphomatous Polyposis in Lymphoid Malignancies

• Micah Tratt*

DOI: 10.35248/2157-2518.25.16.004

Perspective

Genotoxicity as a Predictor of Carcinogenic Potential in Chemical and Pharmaceutical Substances

• Dominic Kemps*

DOI: 10.35248/2157-2518.25.16.005

Epigenetic Regulation and Gene Expression in Cancer Progression, 2025

Commentary

Epigenetic Reprogramming in Cancer with Novel Biomarkers and Targets

• Marco Salvatore*

DOI: 10.35248/2157-2518.25.16.001

Commentary

Gene Expression Modulation by Epigenetic Alterations in Cancer

• Paula Argente*

DOI: 10.35248/2157-2518.25.16.002

Commentary

The Cancer Epigenome and its Role in Tumor Progression

• Signe MacLennan*

DOI: 10.35248/2157-2518.25.16.003

Opinion Article

Advances in DNA Methyltransferase Inhibitors for Cancer Therapy

• Ciro Isidoro*

DOI: 10.35248/2157-2518.25.16.004

Perspective

The Role of the Tumor Microenvironment in Therapy Resistance

• Owen Chapman*

DOI: 10.35248/2157-2518.25.16.005

Volume 15, Issue 3, 2024

Review Article

Oxaliplatin-Related Hepatic Sinusoidal Obstruction Syndrome: Updated Biological Pathway Analysis

• Kazumi Fujioka*

DOI: 10.35248/2157-2518.24.15.445

Commentary

The Potential of the Immune System to Fight Cancer in Immuno-Oncology

• Abigail Shoben*

DOI: 10.35248/2157-2518.24.15.449

Commentary

An Essential Guide of Chemotherapy for Cancer Patients

• Anna Schmutz*

DOI: 10.35248/2157-2518.24.15.446

Perspective

Early Detection and Advanced Treatment Strategies in Hidradenocarcinoma

• Christian Moen*

DOI: 10.35248/2157-2518.24.15.448

Volume 16, Issue 2, 2025

Perspective

Organisation of Rehabilitation in Oncology Patients–to Whom? When? to What Extent? the Oncologist's View

• Robert Wiraszka*

DOI: 10.35248/2157-2518.25.16.469

Research Article

Therapeutic Effects of Hybrid Liposomes against Triple Negative Mouse Breast Cancer in vitro and in vivo

• Hideaki Ichihara*, Suguru Miyamoto, Junna Takai, Masaki Okumura, Koichi Goto and Yoko Matsumoto

DOI: 10.35248/2157-2518.25.16.470

Research Article

Growth Suppression of Triple-Negative Breast Cancer Cells by the Photodynamic Therapy Effect of Hybrid Liposomes Containing Indocyanine Green

• Masaki Okumura, Hinano Otsuka, Junna Takai, Koichi Goto, Yoko Matsumoto and Hideaki Ichihara*

DOI: 10.35248/2157-2518.25.16.471

Perspective

The Impact of Environmental Carcinogens on Human Health

• Sumira Malik*

DOI: 10.35248/2157-2518.25.16.473

Commentary

The Applications of Gene Therapy in the Treatment of Genetic and Acquired Diseases

• Laertis Ikonomou*

DOI: 10.35248/2157-2518.25.16.472

Next-Generation Sequencing Applications in Carcinogenesis Research, 2025

Short Communication

The Oncogene Paradigm in Cancer Biology and Therapeutics

• Chang Moo*

DOI: 10.35248/2157-2518.25.S50.005

Commentary

Comprehensive Mutation Profiling in Carcinogenesis Using Next Generation Sequencing

• Joanna Wirkus*

DOI: 10.35248/2157-2518.25.S50.001

Commentary

The Role of Whole Genome Sequencing in Understanding Cancer Mutations

• Guangjun Wang*

DOI: 10.35248/2157-2518.25.S50.002

Perspective

Insights into Tumor Biology from Single Cell Sequencing Approaches

• Paula Bazo*

DOI: 10.35248/2157-2518.25.S50.003

Perspective

Implications of Tumor Heterogeneity for Cancer Treatment

• Maria Palmieri*

DOI: 10.35248/2157-2518.25.S50.004